Donald E. Slaughter
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Cell Biology top 10%
- Microtubule and mitosis dynamics
Papers in
-
- Pharmacogenetics and Drug Metabolism 7
- Drug-Induced Hepatotoxicity and Protection 3
-
- Microtubule and mitosis dynamics 3
- Co-authors
- Robert P. Hanzlik (3 shared papers)Kamlesh P. Vyas (6 shared papers)Byron H. Arison (3 shared papers)Lynn M. Gorham (2 shared papers)Thomayant Prueksaritanont (2 shared papers)Xiaoming Yu (1 shared paper)Bennett Ma (1 shared paper)Lida Liu (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Medicinal Chemistry (2 papers)The Journal of Clinical Pharmacology (2 papers)Drug Metabolism and Disposition (2 papers)The Journal of Organic Chemistry (1 paper)
- Partner nations
- United States
In The Last Decade
Donald E. Slaughter
17 papers receiving 872 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 317
- Cell Biology 106
- Pharmaceutical Science 46
- Organic Chemistry 200
- Toxicology 23
Countries citing papers authored by Donald E. Slaughter
This map shows the geographic impact of Donald E. Slaughter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald E. Slaughter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald E. Slaughter more than expected).
Fields of papers citing papers by Donald E. Slaughter
This network shows the impact of papers produced by Donald E. Slaughter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald E. Slaughter. The network helps show where Donald E. Slaughter may publish in the future.
Co-authors
The 25 scholars most cited alongside Donald E. Slaughter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s. | 1997 | 245 |
| 2 | 2008 | 147 | |
| 3 | 2003 | 89 | |
| 4 | 1997 | 87 | |
| 5 | 1991 | 61 | |
| 6 | 2006 | 58 | |
| 7 | Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor. | 2001 | 46 |
| 8 | 2006 | 41 | |
| 9 | 1999 | 32 | |
| 10 | 1990 | 31 | |
| 11 | 2000 | 28 | |
| 12 | 1993 | 22 | |
| 13 | 2001 | 17 | |
| 14 | 2007 | 13 | |
| 15 | 2003 | 12 | |
| 16 | 2000 | 9 | |
| 17 | Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs. | 1998 | 8 |
About Donald E. Slaughter
Donald E. Slaughter is a scholar working on Pharmacology, Cell Biology, Organic Chemistry, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine, having authored 17 papers that have together received 946 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Synthesis and biological activity (4 papers), Microtubule and mitosis dynamics (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Migraine and Headache Studies (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Carcinogens and Genotoxicity Assessment (1 paper) and Chemical Reaction Mechanisms (1 paper). The work is most often cited by research in Pharmacology (317 citations), Cell Biology (106 citations), Pharmaceutical Science (46 citations), Organic Chemistry (200 citations) and Toxicology (23 citations). Donald E. Slaughter has collaborated with scholars based in United States. Frequent co-authors include Robert P. Hanzlik, Kamlesh P. Vyas, Byron H. Arison, Lynn M. Gorham, Thomayant Prueksaritanont, Xiaoming Yu, Bennett Ma, Lida Liu, A. David Rodrigues and Magang Shou. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, The Journal of Clinical Pharmacology, Drug Metabolism and Disposition and The Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.